当前位置:首页 - 行情中心 - 国药现代(600420) - 财务分析 - 现金流量表

国药现代

(600420)

  

流通市值:120.09亿  总市值:134.65亿
流通股本:11.96亿   总股本:13.41亿

现金流量表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金11,311,900,526.798,024,058,613.725,321,280,999.622,458,359,184.9
收到的税费返还75,847,533.1758,806,063.6449,454,380.141,190,012.96
收到其他与经营活动有关的现金605,954,113.04484,677,295.88421,355,423.35167,321,463.43
经营活动现金流入的平衡项目0000
经营活动现金流入小计11,993,702,1738,567,541,973.245,792,090,803.072,666,870,661.29
购买商品、接受劳务支付的现金4,374,052,674.493,223,189,185.582,113,439,025.43948,988,827.05
支付给职工以及为职工支付的现金1,633,129,543.311,227,638,626.86846,939,564.69481,541,704.05
支付的各项税费827,480,346.36650,815,042.31490,502,997.78249,327,236.77
支付其他与经营活动有关的现金3,438,665,820.82,019,356,171.831,429,506,565.38717,452,585.51
经营活动现金流出的平衡项目0000
经营活动现金流出小计10,273,328,384.967,120,999,026.584,880,388,153.282,397,310,353.38
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额1,720,373,788.041,446,542,946.66911,702,649.79269,560,307.91
二、投资活动产生的现金流量:
收回投资收到的现金2,007,363.271,356,023.891,356,023.891,356,023.89
取得投资收益收到的现金26,191,023.7226,051,263.78--
处置固定资产、无形资产和其他长期资产收回的现金净额10,958,823.721,328,920.8825,423.4229,623.4
投资活动现金流入的平衡项目0000
投资活动现金流入小计39,157,210.7128,736,208.472,181,447.291,585,647.29
购建固定资产、无形资产和其他长期资产支付的现金357,193,792.2248,694,123.69173,957,473.3131,448,715.74
支付其他与投资活动有关的现金1,044,850,916.67493,498,222.22--
投资活动现金流出的平衡项目0000
投资活动现金流出小计1,402,044,708.87742,192,345.91173,957,473.3131,448,715.74
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-1,362,887,498.16-713,456,137.44-171,776,026.01-129,863,068.45
三、筹资活动产生的现金流量:
取得借款收到的现金45,000,00045,000,00025,000,000-
筹资活动现金流入平衡项目000-
筹资活动现金流入小计45,000,00045,000,00025,000,000-
偿还债务支付的现金752,800,000752,800,000727,800,000727,800,000
分配股利、利润或偿付利息支付的现金364,159,004.86338,500,067.57146,013,566.4864,391,863.42
其中:子公司支付给少数股东的股利、利润174,804,142.7187,032,635.486,661,489.155,107,617.57
支付其他与筹资活动有关的现金21,431,162.4514,520,580.4713,774,784.435,273,738.79
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,138,390,167.311,105,820,648.04887,588,350.91797,465,602.21
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-1,093,390,167.31-1,060,820,648.04-862,588,350.91-797,465,602.21
四、汇率变动对现金及现金等价物的影响32,072,779.7124,787,371.621,377,290.6-6,181,466.6
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-703,831,097.72-302,946,467.2-121,284,436.53-663,949,829.35
加:期初现金及现金等价物余额5,834,875,955.525,834,875,955.525,834,875,955.525,834,875,955.52
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额5,131,044,857.85,531,929,488.325,713,591,518.995,170,926,126.17
补充资料:
净利润964,610,734.18-514,521,310.56-
资产减值准备61,050,750.61-44,862,145.75-
固定资产和投资性房地产折旧767,193,287.58-369,652,763.29-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧767,193,287.58-369,652,763.29-
无形资产摊销37,290,253.94-18,019,096.36-
长期待摊费用摊销6,359,327.52-2,994,356.22-
处置固定资产、无形资产和其他长期资产的损失31,845,024.31-608,300.68-
固定资产报废损失2,560,421.78-333,129.17-
公允价值变动损失--3,852,000-
财务费用57,883,690.44-37,752,851.78-
投资损失-27,453,725.69-8,009,983.45-
递延所得税-11,446,123.97-7,365,418.82-
其中:递延所得税资产减少-10,297,847.97-8,836,832.92-
递延所得税负债增加-1,148,276--1,471,414.1-
存货的减少163,267,685.67-108,399,594.14-
经营性应收项目的减少485,426,559.99-8,342,387.91-
经营性应付项目的增加-832,616,234.65--220,211,756.5-
现金的期末余额5,131,044,857.8-5,713,591,518.99-
减:现金的期初余额5,834,875,955.52-5,834,875,955.52-
公告日期2024-03-302023-10-282023-08-292023-04-26
审计意见(境内)标准无保留意见
TOP↑